1. Home
  2. GRFS vs KMPR Comparison

GRFS vs KMPR Comparison

Compare GRFS & KMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • KMPR
  • Stock Information
  • Founded
  • GRFS 1940
  • KMPR 1990
  • Country
  • GRFS Spain
  • KMPR United States
  • Employees
  • GRFS 23737
  • KMPR N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • KMPR Property-Casualty Insurers
  • Sector
  • GRFS Health Care
  • KMPR Finance
  • Exchange
  • GRFS Nasdaq
  • KMPR Nasdaq
  • Market Cap
  • GRFS 5.5B
  • KMPR 4.5B
  • IPO Year
  • GRFS 2006
  • KMPR N/A
  • Fundamental
  • Price
  • GRFS $8.05
  • KMPR $66.14
  • Analyst Decision
  • GRFS Sell
  • KMPR Strong Buy
  • Analyst Count
  • GRFS 2
  • KMPR 5
  • Target Price
  • GRFS $10.50
  • KMPR $75.20
  • AVG Volume (30 Days)
  • GRFS 1.3M
  • KMPR 317.1K
  • Earning Date
  • GRFS 01-01-0001
  • KMPR 01-30-2025
  • Dividend Yield
  • GRFS N/A
  • KMPR 1.87%
  • EPS Growth
  • GRFS N/A
  • KMPR N/A
  • EPS
  • GRFS 0.27
  • KMPR 4.20
  • Revenue
  • GRFS $7,814,096,584.00
  • KMPR $4,639,300,000.00
  • Revenue This Year
  • GRFS $8.86
  • KMPR N/A
  • Revenue Next Year
  • GRFS $7.00
  • KMPR $12.15
  • P/E Ratio
  • GRFS $35.12
  • KMPR $15.82
  • Revenue Growth
  • GRFS 7.21
  • KMPR N/A
  • 52 Week Low
  • GRFS $5.30
  • KMPR $47.12
  • 52 Week High
  • GRFS $12.15
  • KMPR $73.01
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 51.40
  • KMPR 39.03
  • Support Level
  • GRFS $7.29
  • KMPR $66.41
  • Resistance Level
  • GRFS $7.85
  • KMPR $68.21
  • Average True Range (ATR)
  • GRFS 0.33
  • KMPR 1.38
  • MACD
  • GRFS 0.06
  • KMPR -0.71
  • Stochastic Oscillator
  • GRFS 77.22
  • KMPR 1.61

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About KMPR Kemper Corporation

Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.

Share on Social Networks: